ZIOP (Ziopharm Oncology IN) stock is currently covered by 5 analysts. The average analyst rating isĀ 3.2 out of 5.

ZIOP analysts have given it a high price target of $6, mean price target of $5.5, and a low price target of $5.

ZIOP currently has an estimated 12-Month price forecast of $5.5 based on the average analyst price target.

[wpdatatable id=10 var1=ZIOP]

Leave a Reply

Your email address will not be published. Required fields are marked *